Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +45.17%
#2 Mubarak Mubarak +41.77%
#3 Pons Pons +38.24%
#4 Bitway Bitway +33.87%
#5 Starpower Starpower +30.66%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.20%
#7 TENDIES TENDIES +30.00%
#8 SkyAI SkyAI +24.19%
#9 Ocean Protocol Ocean Protocol +20.97%
#10 StonkBroker StonkBroker +19.71%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Kringle Pharma, Inc. Kringle Pharma, Inc.

Kringle Pharma, Inc.

4884
Clasificación en acciones #29204
Kringle Pharma, Inc. specializes in the innovation, production, and... Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Precio por acción
$2.77
Capitalización bursátil
$22.40M
Cambio (1 día)
-0.93%
Cambio (1 año)
-17.48%
País
JP
Comercio Kringle Pharma, Inc. (4884)

Categoría

Healthcare
Ganancias de Kringle Pharma, Inc. (4884)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Kringle Pharma, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Kringle Pharma, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH